B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Neflamapimod

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Neflamapimod, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

dasatinib
18 shared targets
masitinib
16 shared targets
nilotinib
24 shared targets
bafetinib
14 shared targets
saracatinib
18 shared targets
ponatinib
21 shared targets
tivozanib
13 shared targets
doramapimod
24 shared targets
glesatinib
10 shared targets
cep
13 shared targets
Loading evidence profile...

This evidence profile for Neflamapimod is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.